Alex Abramson's Potential

Conflicts of Interest

2021 Patent applications filed describing flexible electronic sensors for tumor regression monitoring

2019- Received consulting fees from Novo Nordisk

2019 Received consulting fees from Eli Lilly

2016-2019 Patent applications filed describing oral biologic drug delivery systems, gastric retention systems, electronic capsules, and transdermal methods of drug delivery

2016-2019 Research funded By Novo Nordisk Pharmaceuticals on oral biologic drug delivery

2015 Worked for Accenture Federal Services

2010-2012 Worked for Missouri Analytical Labs